共 50 条
- [32] Efficacy and Safety of Tofacitinib in Moderate and Severe Ulcerative Colitis in Real Clinical Practice: 3 Years of Observation AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S7 - S7
- [33] Sustained Steroid Free Remission at One Year in Corticosteroid Dependent Ulcerative Colitis Patients on Vedolizumab AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S406 - S406
- [35] Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S427 - S429
- [36] Rates of clinical remission among patients with Ulcerative Colitis from real-world clinical practice settings from Germany JOURNAL OF CROHNS & COLITIS, 2022, 16 : I466 - I467
- [37] Rates of clinical remission among patients with Ulcerative Colitis from real-world clinical practice settings from Germany JOURNAL OF CROHNS & COLITIS, 2022, 16 : I466 - I467
- [39] The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: results from the tofacitinib ulcerative colitis clinical programme JOURNAL OF CROHNS & COLITIS, 2018, 12 : S23 - S23